Carbetocin市場:目前分析與預測(2022-2030年)

由於產品頻繁推出，預計Carbetocin市場在預測期內將以 5% 的複合年增長率強勁增長。例如，2021年9月，雅培實驗室推出了Carbetocin單劑量製劑，用於預防產後出血。

為了更好地了解行業市場採用情況，市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、意大利、西班牙、歐洲其他地區）、亞太地區（中國） 、日本、印度）、韓國、澳大利亞和亞太地區其他地區），以及基於其全球影響力的其他地區。2021年，北美將主導Carbetocin市場。這是由於美國等主要經濟體的存在，以及高醫療保健支出是該地區Carbetocin市場增長的主要原因。例如，根據加拿大健康信息研究所的數據，2022年加拿大的醫療保健總支出約為3310億美元，佔加拿大人均支出8563美元。

目錄

第1章 市場簡介

• 市場定義
• 主要目的
• 相關利益者
• 限制事項

第2章 調查手法或前提

• 調查流程
• 調查手法
• 受訪者簡介

第3章 市場摘要

第4章 摘要整理

第5章 全球Carbetocin市場上新型冠狀病毒感染疾病(COVID-19)的影響

第6章 全球Carbetocin市場收益，2020-2030年

第7章 市場洞察:各類型

• 首發醫藥品
• 學名藥

第8章 市場洞察:各終端用戶

• 醫院
• 診所
• 其他

第9章 市場洞察:各地區

• 北美的Carbetocin市場
  • 美國
  • 加拿大
  • 其他北美地區
• 歐洲的Carbetocin市場
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲地區
• 亞太地區的Carbetocin市場
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • APAC的其他各國
• 其他地區的Carbetocin市場

第10章 Carbetocin市場動態

• 推動市場要素
• 市場課題
• 影響分析

第11章 Carbetocin市場機會

第12章 Carbetocin市場趨勢

第13章 需求面和供給面的分析

• 需求面分析
• 供給面分析

第14章 價值鏈分析

第15章 價格分析

第16章 策略性洞察能力

第17章 競爭模式

• 競爭情形
  • 波特的五力分析

第18章 企業簡介

• Ferring B.V.
• Hybio Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Beacon Pharmaceuticals Limited
• SGPharma Pvt. Ltd.
• Taj Pharmaceuticals
• Abbott
• MANUS AKTTEVA BIOPHARMA LLP
• Enomark
• Sun Pharmaceutical Industries Ltd

第19章 免責聲明

Carbetocin is a synthetic hormone used to prevent postpartum hemorrhage (PPH) in women who have just given birth. It works by stimulating contractions in the uterus to prevent excessive bleeding. Carbetocin is administered as an injection and is typically given after vaginal delivery or after a cesarean section. The market for carbetocin is expected to witness growth due to the increasing number of pregnancies and high fertility rate globally. For instance, as per the World Bank, in 2020, the global fertility rate of births per woman accounted for 2.3 and is expected to reach 2.1 by year 2050.

Carbetocin Market is expected to grow at a strong CAGR of 5% during the forecast period owing to the frequent product launches. For instance, In September 2021, Abbott Laboratory launched a single-dose formulation of carbetocin to prevent post partem hemorrhage.

Based on type, the market is segmented into original drug and generic drug. As per our analysis, the diagnosis segment acquired a major share in 2021. Duratocin is the original and the most widely used brand of carbetocin, and it is available in many countries around the world. This is mainly due to the high popularity of the brand and the quality of the brand offered by the companies attributes to the large share of the segment.

Based on the end-user, the market is segmented into hospitals, clinics, and others. The clinics segment is expected to grow with a higher CAGR in the carbetocin market during the forecast period. The maternity clinics have specialized professionals for gynae treatments is the main reason for the fast growth of the segment in the carbetocin market.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North American region held the dominant share of the carbetocin market in 2021. This is mainly due to the presence of major economies such as the U.S., along with the high healthcare spending is the main reason for the market growth of the region in the carbetocin market. For example, as per the Canadian Institute for Health Information, total health spending in Canada was around USD 331 billion in 2022 and per capita expenditure in Canada accounted for USD 8563.

Some of the major players operating in the market include: Ferring B.V.; Hybio Pharmaceutical Co., Ltd.; Pfizer Inc.; Beacon Pharmaceuticals Limited; SGPharma Pvt. Ltd.; Taj Pharmaceuticals; Abbott; MANUS AKTTEVA BIOPHARMA LLP; Enomark; and Sun Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Carbetocin Market
• 2.2. Research Methodology of the Carbetocin Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL CARBETOCIN MARKET COVID-19 IMPACT

6 GLOBAL CARBETOCIN MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY TYPE

• 7.1. Original Drug
• 7.2. Generic Drug

8 MARKET INSIGHTS BY END-USER

• 8.1. Hospitals
• 8.2. Clinics
• 8.3. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America Carbetocin Market
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe Carbetocin Market
  • 9.2.1. Germany
  • 9.2.2. UK
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific Carbetocin Market
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Australia
  • 9.3.5. South Korea
  • 9.3.6. Rest of APAC
• 9.4. Rest of the World Carbetocin Market

10 CARBETOCIN MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 CARBETOCIN MARKET OPPORTUNITIES

12 CARBETOCIN MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

• 18.1. Ferring B.V.
• 18.2. Hybio Pharmaceutical Co., Ltd.
• 18.3. Pfizer Inc.
• 18.4. Beacon Pharmaceuticals Limited
• 18.5. SGPharma Pvt. Ltd.
• 18.6. Taj Pharmaceuticals
• 18.7. Abbott
• 18.8. MANUS AKTTEVA BIOPHARMA LLP
• 18.9. Enomark
• 18.10. Sun Pharmaceutical Industries Ltd

19 DISCLAIMER